Lifecare Q3 2024: Steady progress but veterinary launch postponed - Redeye

Redeye updates its view on Lifecare following its Q3 report. Despite the anticipated delay in the veterinary market launch, the company continues to make steady progress in key areas, including production automation, clinical validation, and business development.

Länk till analysen i sin helhet: https://www.redeye.se/research/1055666/lifecare-q3-2024-steady-progress-but-veterinary-launch-postponed?utm_source=finwire&utm_medium=RSS